These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11556944)

  • 1. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.
    Turner BJ; Fleishman JA; Wenger N; London AS; Burnam MA; Shapiro MF; Bing EG; Stein MD; Longshore D; Bozzette SA
    J Gen Intern Med; 2001 Sep; 16(9):625-33. PubMed ID: 11556944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users.
    Laine C; Hauck WW; Turner BJ
    Med Care; 2002 Oct; 40(10):976-95. PubMed ID: 12395030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
    Pence BW; Miller WC; Gaynes BN; Eron JJ
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):159-66. PubMed ID: 17146374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Outcomes of HIV-Infected People with Mental Illness.
    Yehia BR; Stephens-Shield AJ; Momplaisir F; Taylor L; Gross R; Dubé B; Glanz K; Brady KA
    AIDS Behav; 2015 Aug; 19(8):1491-500. PubMed ID: 25931243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported antiretroviral therapy in injection drug users.
    Celentano DD; Vlahov D; Cohn S; Shadle VM; Obasanjo O; Moore RD
    JAMA; 1998 Aug; 280(6):544-6. PubMed ID: 9707145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dysthymia on receipt of HAART by minority HIV-infected women.
    Turner BJ; Fleishman JA
    J Gen Intern Med; 2006 Dec; 21(12):1235-41. PubMed ID: 17105522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.
    McGowan CC; Weinstein DD; Samenow CP; Stinnette SE; Barkanic G; Rebeiro PF; Sterling TR; Moore RD; Hulgan T
    PLoS One; 2011 Apr; 6(4):e18462. PubMed ID: 21541016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
    Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
    AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users.
    Loughlin A; Metsch L; Gardner L; Anderson-Mahoney P; Barrigan M; Strathdee S
    AIDS Care; 2004 May; 16(4):485-500. PubMed ID: 15203416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen.
    Turner BJ; Zhang D; Laine C; Pomerantz RJ; Cosler L; Hauck WW
    J Acquir Immune Defic Syndr; 2001 May; 27(1):20-9. PubMed ID: 11404516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada.
    O'Neil CR; Palmer AK; Coulter S; O'Brien N; Shen A; Zhang W; Montaner JS; Hogg RS
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):134-41. PubMed ID: 22318879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia.
    Chan PY; Joseph MA; Des Jarlais DC; Uusküla A
    Int J STD AIDS; 2018 Jan; 29(1):13-22. PubMed ID: 28618981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of illicit drug use and substance abuse treatment on adherence to HAART.
    Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA;
    AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to use of free antiretroviral therapy in injection drug users.
    Strathdee SA; Palepu A; Cornelisse PG; Yip B; O'Shaughnessy MV; Montaner JS; Schechter MT; Hogg RS
    JAMA; 1998 Aug; 280(6):547-9. PubMed ID: 9707146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.